Eva Pros

<i>MAX</i> Inactivation in Small Cell Lung Cancer Disrupts MYC–SWI/SNF Programs and Is Synthetic Lethal with BRG1

Octavio A. Romero, Manuel Torres-Diz, Eva Pros et al. · Cancer Discovery · 2013 · 173 citations

Cancer Biology, Tumor Biology, Oncology +16

Nature and mRNA effect of 282 different <i>NF1</i> point mutations: focus on splicing alterations

Eva Pros, Thamar Martín, Pere Fábregas et al. · Human Mutation · 2008 · 122 citations · Full text

Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies <i>B2M</i> Inactivation Impairing Immunorecognition

Carolina Pereira, Pol Giménez‐Xavier, Eva Pros et al. · Clinical Cancer Research · 2016 · 101 citations

<i>MET</i> -Oncogenic and <i>JAK2</i> -Inactivating Alterations Are Independent Factors That Affect Regulation of PD-L1 Expression in Lung Cancer

Maria Saigí, Juan J. Alburquerque-Béjar, Anne Mc Leer‐Florin et al. · Clinical Cancer Research · 2018 · 98 citations · Full text

Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH

Carles Garcia-Linares, Juana Fernández‐Rodríguez, Ernest Terribas et al. · Human Mutation · 2010 · 82 citations · Full text

Cancer Pathology, Genetics, Pathology +20